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Abstract 
Recurrent lobular breast carcinoma manifesting as a cutaneous neck nodule in a woman, 
14 years after successful chemotherapy, illustrates the importance of following at-risk 
patients with a high level of clinical suspicion. This case emphasizes the value of 
combining clinical findings with appropriate histopathologic and immunohistochemical 
analysis when evaluating a cutaneous lesion in such a patient. 
 
Introduction 
Breast carcinoma is the most common malignancy in women, and accounts for the 
most common primary source of cutaneous metastases [1–3, 6–9]. Cutaneous metastatic 
lesions may present as solitary nodules or nondescript localized rashes. For this reason, it 
is important for clinicians to consider a differential diagnosis of malignancy when 
evaluating a cancer survivor who demonstrates a benign-appearing skin finding, even if 
the lesion is distant in either location or time to the primary lesion [4]. Once an 
interderminant skin lesion is removed, immunohistochemical stains can prove invaluable 
in expediting accurate diagnosis by identifying expression profiles for primary tumors. 
Expression profiles helpful in differentiating breast cancer from other primary 
carcinomas include cytokeratin 7 (CK7), cytokeratin 20 (CK20), estrogen receptor (ER), 
progesterone receptor (PR), gross cystic disease fluid protein 15 (GCDFP-15), thyroid 
transcription factor 1 (TTF-1) and CDX2 (an intestinal epithelia-specific nuclear 
transcription factor) [5]. We present a case in which a patient presented with cutaneous 
metastases as the primary sign of disease recurrence over 15 years after her initial  
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diagnosis and treatment. A low threshold for biopsy and detailed immunohistochemical 
staining was essential to making the correct diagnosis and rapidly initiating treatment. 
Case Report 
The patient was a 71-year-old Caucasian female with a remote history of breast carcinoma, 
successfully treated with simple mastectomy in 1993 followed by chemotherapy (tamoxifen) for 5 years. 
She presented to the dermatology clinic for evaluation of a small, non-pruritic, non-tender nodule on 
her posterior right neck that had been slowly enlarging over the past year. The patient denied a history 
of ulceration, bleeding, discharge, or pain. 
On physical exam, the patient had a 0.5 × 0.3 cm flesh-colored, soft, freely mobile nodule on her 
right neck. There was no ulceration, tenderness to palpation, erythema or edema. There was no palpable 
cervical or axillary lymphadenopathy. A punch biopsy was performed and submitted for histologic 
examination. The clinical diagnosis was sebaceous cyst. 
On microscopic examination, within the dermis there were infiltrative tumor cells with enlarged, 
hyperchromatic nuclei (fig. 1). The tumor cells infiltrated between collagen bundles in a single file 
pattern (fig. 2). Perineural infiltration was also identified, along with occasional tumor cells in mitoses. 
A partial immunohistochemical profile was performed and interpreted with appropriately staining 
control slides. The tumor cells were shown to be positive for cytokeratin-AE1/AE3, CK7, ER, PR, and 
GCDFP-15. The tumor cells showed absence of staining for CK20, TTF-1, and CD45 (fig. 3). The 
histomorphology combined with the immunohistochemical profile were consistent with metastatic 
lobular carcinoma involving the skin. 
The patient was referred to medical oncology where she underwent chest, abdomen, and pelvic 
computed tomography, magnetic resonance imaging of the head, and a positron emission tomography 
scan which showed no evidence of metastatic disease. She did have elevated tumor markers, however, 
which included a carcinoembryonic antigen (CEA) of 64 ng/dl and a CA15.3 of 314. The patient was 
treated with an aromatase inhibitor (anastrozole), which resulted in complete clearance of the skin 
lesion. She has had no signs of recurrence by physical examination after 3 months of follow-up. 
Discussion 
Cutaneous metastases are present in 23.9% of breast carcinomas over the course of the 
disease [1, 2]. In one study, skin metastases were seen at the time of diagnosis in 6.3% of 
patients, and 3.5% had cutaneous involvement as the presenting sign of disease [1]. 
Grossly, most cutaneous metastases present as dermal or subcutaneous nodules that 
are firm, painless, and often immobile [9]. Their growth pattern is not predictable, and 
they may grow rapidly, appear in clusters, or grow slowly and appear as a solitary lesion. 
In our female patient, the lesion was located on the right posterior neck, which is 
consistent with the propensity of lobular breast carcinoma to distantly metastasize. Our 
patient had a remote history of breast cancer in 1993, status-post simple mastectomy and 
chemotherapy. 
Immunohistochemical evaluation is an increasingly important diagnostic tool for 
characterizing the primary malignancy in cutaneous metastases. Park et al. [5] evaluated 
the organ-specific immunostaining profiles that provided high sensitivity, specificity, and 
positive predictive value in detecting primary adenocarcinomas. The expression profile 
GCDFP-15(+)/TTF-1(–)/CDX2(–)/CK7(+)/CK20(–) was determined to have a sensitivity 
of 74.4%, a specificity of 99.6%, and a positive predictive value of 96.9% in identifying the 
breast as the primary site of metastatic adenocarcinoma [5]. Although no available 
marker has shown complete site specificity, GCDFP-15 is considered a relatively specific 
and sensitive marker of breast cancers [10, 11].  
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Histologically, the differential diagnosis included metastatic lobular carcinoma, 
metastatic gastric carcinoma (signet ring cell carcinoma) [5], primary adnexal carcinoma 
[12], and lymphoma. No histological features for adnexal differentiation were present to 
suggest a primary skin tumor. The immunohistochemical profile of CK7(+), CK20(–), 
ER(+), PR(+), GCDFP-15(+) ruled out a primary gastric carcinoma. The absence of CD45 
ruled out a lymphoma. 
Invasive lobular breast carcinoma accounts for 0.7 to 14% of all primary invasive breast 
carcinomas [13]. This report emphasizes the importance of a combination of clinical, 
histologic, and immunohistochemical analyses to accurately identify cutaneous 
involvement in metastatic breast carcinoma. A high level of suspicion is warranted when 
evaluating cutaneous lesions in patients with a past history of breast carcinoma, even if 
the patient was successfully treated in the distant past. 
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Fig. 1. Infiltrative tumor cells within the dermis with large, hyperchromatic nuclei (microscopic 
magnification ×10). 
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Fig. 2. Tumor cells infiltrate between collagen bundles in a single file pattern (microscopic 
magnification ×40). 
 
 
 
Fig. 3. The immunohistochemical profile shows tumor cells positive for ER, CK7 and negative for 
CK20. 
 
 
  
Case Rep Oncol 2009;2:24–29 
DOI: 10.1159/000204789 
Published online: February 26, 2009  © 2009 S. Karger AG, Basel 
ISSN 1662–6575 
www.karger.com/cro 
 
 
28
 
 
 
 
 
 
  
Case Rep Oncol 2009;2:24–29 
DOI: 10.1159/000204789 
Published online: February 26, 2009  © 2009 S. Karger AG, Basel 
ISSN 1662–6575 
www.karger.com/cro 
 
 
29
References 
1  Lookingbill DP, Spangler N, Sexton FM: Skin involvement as the presenting sign 
of internal carcinoma. J Am Acad Dermatol 1990;22:19–26. 
2  Schwartz RA: Cutaneous metastatic disease. J Am Acad Dermatol 1995;33:161–
185. 
3  Schwartz RA, Wiederkehr M, Lambert WC: Secondary mucinous carcinoma of 
the skin: metastatic breast cancer. Dermatol Surg 2004;30:234–235. 
4  Schwartz RA: Histopathologic aspects of cutaneous metastatic disease. J Am Acad 
Dermatol 1995;33:649–657. 
5  Park SY, Kim BH, Kim JH, Lee S, Kang GH: Panels of immunohistochemical 
markers help determine primary sites of metastatic adenocarcinoma. Arch Pathol 
Lab Med 2007;131:1561–1567. 
6  Lookingbill DP, Spangler N, Helm KF: Cutaneous metastases in patient with 
metastatic carcinoma: a retrospective study of 4,020 patients. J Am Acad 
Dermatol 1993;29:228–236. 
7  Aizawa H, Aiba S, Takahashi M, et al: Cutaneous metastasis of invasive lobular 
carcinoma of the breast. J Dermatol 1987;14:270–273. 
8  Cotton DWK, Fairris GM: Metastatic breast carcinoma on the lip: case report. 
Dermatologica 1985;171:362–365. 
9  Brownstein MH, Helwig EB: Spread of tumors to the skin. Arch Dermatol 
1973;107:80–86. 
10  Brown RW, Campagna LB, Dunna JK, Cagle PT: Immunohistochemical 
identification of tumor markers in metastatic adenocarcinoma: a diagnostic 
adjunct in the determination of primary site. Am J Clin Pathol 1997;107:12–19. 
11  DeYoung BR, Wick MR: Immunohistologic evaluation of metastatic carcinomas 
of unknown origin: an algorithmic approach. Semin Diagn Pathol 2000;17:184–
193. 
12  Zelger BG, Stelzmueller I, Dunst KM, Zelger B: Solid apocrine carcinoma of the 
skin: report of a rare adnexal neoplasm mimicking lobular breast carcinoma. J 
Cutan Pathol 2008;35:332–336. 
13  Tavassoli FA: Infiltrative lobular carcinoma; in Pathology of the Breast. Appleton 
& Lange, 1992, p 307. 
 